Medical News

RSS

NextGate and NextGen Healthcare partner to advance health information exchange

NextGate, the Enterprise Master Index leader, today announced a partnership with NextGen Healthcare, a leading provider of healthcare information systems and connectivity solutions, aimed at improving healthcare organizations' ability to combine data from disparate systems and create a unified, complete record for each patient.

14 Oct 2010

Scientists unveil quality control mechanism of immune system to destroy pathogens

An Australian team of scientists has uncovered a quality control mechanism that must take place for our immune system to subsequently effectively destroy harmful viruses and bacteria.

14 Oct 2010

NIH awards grant to Bavarian to advance early research in filoviruses

Bavarian Nordic A/S announced today that the company has received funding from the U.S. National Institutes of Health (NIH) to advance its early research in filoviruses (Ebola and Marburg virus).

14 Oct 2010

Dyadic International receives sixth USPTO patent

Dyadic International, Inc. a global biotechnology company focused on the discovery, development, manufacture and sale of enzyme and protein products and solutions for the bioenergy, industrial enzyme and biopharmaceutical industries, announced today that it has been issued U.S. Patent No. 7,794,962 by the United States Patent and Trademark Office.

14 Oct 2010

Ligand launches Viviant in Japan and Spain for postmenopausal osteoporosis

Ligand Pharmaceuticals Incorporated today announced that its partner Pfizer, Inc. launched Viviant® (Bazedoxifene) in Japan for the treatment of postmenopausal osteoporosis. Under the brand name Conbriza®, the drug is also marketed in Spain through a co-promotion with Almirall, an international pharmaceutical company based in Spain.

14 Oct 2010

Stimulating brain's nicotine receptors may eliminate side effects of Alzheimer's drug: Research

A team of neuroscientists has discovered important new information in the search for an effective treatment for Alzheimer's disease, the debilitating neurological disorder that afflicts more than 5.3 million Americans and is the sixth-leading cause of death in the United States. Hey-Kyoung Lee, associate professor in the University of Maryland Department of Biology, and her research team have shown that they may be able to eliminate debilitating side effects caused by a promising Alzheimer's drug by stimulating the brain's nicotine receptors.

14 Oct 2010

State roundup: N.Y.'s retiree health benefits crisis; Colorado referendum

The New York Times: "The cities, counties and authorities of New York have promised more than $200 billion worth of health benefits to their retirees while setting aside almost nothing, putting the public work force on a collision course with the taxpayers who are expected to foot the bill. … The total cost appears in a report to be issued on Wednesday by the Empire Center for New York State Policy, a research organization that studies fiscal policy.

14 Oct 2010

Acceleron announces ACE-031 Phase 1b study results

Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including muscle, bone, fat, red blood cells and the vasculature, today announced preliminary results from a Phase 1b study to assess the safety, tolerability and pharmacodynamic (PD) activity of ACE-031 following multiple ascending doses in healthy postmenopausal volunteers.

14 Oct 2010

Walking six miles per week preserves memory in old age

New research suggests that walking at least six miles per week may protect brain size and in turn, preserve memory in old age, according to a study published in the October 13, 2010, online issue of Neurology®, the medical journal of the American Academy of Neurology.

14 Oct 2010

XenoPort to present XP23829 preclinical data at ECTRIMS meeting

XenoPort, Inc. announced today that it will present data on a new preclinical product candidate, XP23829, at the upcoming 26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) meeting in Gothenburg, Sweden, October 13 - 16, 2010.

14 Oct 2010

Today's Opeds: Individual mandate in court, on ballot and in campaigns

The first federal court decision on the constitutionality of the new health care reform law upheld its validity and dealt a well-deserved setback to opponents who are trying to overturn it.

14 Oct 2010

Antidepressant Reboxetine ineffective: Review

According to a new study, an antidepressant prescribed over the last 13 years is ineffective and potentially harmful. The drug in question is called Reboxetine and is available under the name of Edronax. The study showed that it works no better than a placebo.

13 Oct 2010

Children recognise signs of neglect in peers: Survey

Researchers for Action for Children in a survey of over 3,000 eight to 12 year-olds found that 44% of children under 12 have seen other children who were dirty and smelled. Nearly two-thirds of children have seen suspected signs of neglect among their peers in classrooms, playgrounds, neighborhoods and activity clubs.

13 Oct 2010

NHS bonuses under scanner

The NHS bonus scheme is being criticized. The scheme originated in 1948 when the NHS was created. They are available to consultants and are designed to reward excellence in research, teaching and, of course, clinical care.

13 Oct 2010

Taller kids with IVF: Study

A new study has found that children born via IVF are typically taller than those born naturally. Newborn IVF babies created from a fresh embryo transferred back into the mother, also tended to be about 190g lighter than naturally conceived children.

13 Oct 2010

Agfa HealthCare to install first DX-D 500n direct radiography system in Canada at Sunnybrook Health Sciences Centre

Agfa HealthCare, a leading provider of diagnostic imaging and healthcare IT solutions, announces today that it will be installing its DX-D 500n Direct Radiography X-Ray Suite at Sunnybrook Health Sciences Centre in Toronto, Canada. Building upon Agfa HealthCare's expertise and history in imaging, the DX-D 500n completes Agfa HealthCare's digital imaging portfolio.

13 Oct 2010

AusBiotech 2010 set to demystify the impact of US Healthcare Reforms on Australian biotech

Australian biotechnology and pharmaceutical companies are seeking to understand the implications of the US Healthcare Reform Bill, says Australia’s biotechnology industry organisation, AusBiotech. In order to remain compliant and globally competitive, biotechs need to identify and work within a gamut of new requirements, complications and hurdles imposed by this new regulatory environment.

13 Oct 2010

Mesoblast broadens cancer indications for bone marrow transplant product

Australian regenerative medicine company Mesoblast Limited (ASX: MSB, USOTC: MBLTY) today announced that it is broadening the oncology applications of its "off-the-shelf" cell product for expansion of haematopoietic stem cells in patients with blood cancers. Building on the recent clinical success of Mesoblast’s proprietary cell product for expansion of cord blood, the Company will now address new markets where expansion of haematopoietic stem cells can make a meaningful impact on clinical outcomes, including diseases such as multiple myeloma.

13 Oct 2010

Global project to find biological activity in sea organisms suitable for pharmaceutical products

Researchers at the Faculty of Pharmacy at the University of Helsinki are co-ordinating an extensive project which aims to find biological activity from among organisms in the sea which would be suitable for use as a basis for pharmaceutical products. Interesting compounds isolated from organisms in the sea are chemically modified to be more suitable for medical purposes.

13 Oct 2010

ALFA sponsors short films competition about ageism in America

The Assisted Living Federation of America (ALFA), representing senior living providers and the seniors and families they serve, is sponsoring a short films competition about ageism in America. Ageism includes discriminatory and prejudicial practices, attitudes and stereotypes perpetuated particularly against seniors.

13 Oct 2010